Press releasePRNewswire
Caris Life Sciences
CAI · NASDAQ
$31.11+$0.40 (+1.30%)TodayMarket closed ·
Prev close $30.71
Latest news
- NewsAvi Kapoor
Truist Financial, Regions Financial And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
- Press releasePRNewswire
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
- NewsPiero Cingari
Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today
- Press releasePRNewswire
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
- NewsPiero Cingari
S&P 500, Nasdaq Hit Records, Power Stocks Rally on Google's Nuclear Deal: Stock Market Today
- NewsPiero Cingari
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
- Press releasePRNewswire
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect
- Press releasePRNewswire
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
- Press releasePRNewswire
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer
- NewsPiero Cingari
Nasdaq 100 Falls as Hot PCE Inflation Stirs Rate-Hike Bets: Stock Market Today
- NewsPiero Cingari
Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releasePRNewswire
Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
- Press releasePRNewswire
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
- Press releasePRNewswire
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
- Press releasePRNewswire
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test
- Press releasePRNewswire
Caris Life Sciences Announces Dual Listing on NYSE Texas
- Press releasePRNewswire
Caris Life Sciences Announces Share Repurchase Program
- NewsPiero Cingari
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows
- Press releasePRNewswire
Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing
- NewsSurbhi Jain
Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And Biotech
- Press releasePRNewswire
Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek
- Press releaseGlobe Newswire
Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
- Press releasePRNewswire
Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
- Press releasePRNewswire
Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releasePRNewswire
Caris Life Sciences Reports First Quarter 2026 Financial Results
- Press releasePRNewswire
Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis
- Press releasePRNewswire
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
- Press releasePRNewswire
Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients
- Press releasePRNewswire
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
- Press releasePRNewswire
Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026
- Press releasePRNewswire
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
- Press releasePRNewswire
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
- NewsVandana Singh
Why Is Caris Life Sciences Stock Gaining Wednesday?
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.